Edition:
United Kingdom

U.S. Food And Drug Administration Accepts Bristol-Myers Squibb’S Application For Sprycel


Thursday, 30 Aug 2018 

Aug 30 (Reuters) - Bristol-Myers Squibb Co ::U.S. FOOD AND DRUG ADMINISTRATION ACCEPTS BRISTOL-MYERS SQUIBB’S APPLICATION FOR SPRYCEL (DASATINIB) IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA.BRISTOL-MYERS SQUIBB CO - APPLICATION BASED ON RESULTS FROM PHASE 2 CA180-372 STUDY.BRISTOL-MYERS SQUIBB CO - FDA ACTION DATE IS DECEMBER 29, 2018.BRISTOL-MYERS SQUIBB CO - FDA ACTION DATE IS DECEMBER 29, 2018..